Stubbs, Jacob L. http://orcid.org/0000-0002-6634-2228
Taylor, Joseph J.
Siddiqi, Shan H. http://orcid.org/0000-0002-0967-9289
Schaper, Frederic L. W. V. J.
Cohen, Alexander L. http://orcid.org/0000-0001-6557-5866
Drew, William http://orcid.org/0000-0002-9178-8731
Hanlon, Colleen A.
Abdolahi, Amir
Wang, Henry Z.
Honer, William G. http://orcid.org/0000-0002-7628-5108
Panenka, William J.
Fox, Michael D. http://orcid.org/0000-0001-8848-6399
Article History
Received: 12 December 2022
Accepted: 18 August 2023
First Online: 25 September 2023
Competing interests
: C.H. is employed by BrainsWay and has financial interest in the company. S.H.S. is a scientific consultant for Magnus Medical, and a clinical consultant for Acacia Mental Health, Kaizen Brain Center and Boston Precision Neurotherapeutics. S.H.S. has received investigator-initiated research funding from Neuronetics and BrainsWay. S.H.S. has served as a speaker for BrainsWay (branded) and PsychU.org (unbranded, sponsored by Otsuka). S.H.S. owns stock in BrainsWay (publicly traded) and Magnus Medical (not publicly traded). S.H.S. owns intellectual property involving the use of functional connectivity to target TMS. M.D.F. is a consultant for Magnus Medical, Solaris and Boston Scientific, and has intellectual property using connectivity imaging to guide brain stimulation. The remaining authors declare no competing interests.